Article
No disease recurrence, infrequent complications seen at up to 3-year follow-up
FDA grants Regenerative Medicine Advanced Therapy designation to ALLO-316 for RCC
Key updates from the AUA/ASRM male infertility guideline amendment
UGN-102 data published in Journal of Urology as FDA weighs NMIBC approval
Speaking of Urology: Dr. Winter on the use of vaginal estrogen
FDA approves oral sulopenem for uncomplicated urinary tract infection
OASIS: Efficacy of Revi System for urgency incontinence maintained at 2 years